Inhibitors of adrenoreceptor ADRAC2
US-12540134-B2 · Feb 3, 2026 · US
This page is not indexed by search engines while we improve data quality.
Delbeck Martina patents
Delbeck Martina is listed as an inventor on 53 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Delbeck Martina |
| Total patents | 53 |
| First publication | Feb 12, 2015 |
| Latest publication | Feb 3, 2026 |
Notable patents
Publications ranked by popularity score, then publication date.
Diazabicyclic substituted imidazopyrimidines and their use for the treatment of breathing disorders
US-2025154175-A1 · May 15, 2025 · US
A2-adrenoceptor subtype c antagonists for the treatment of sleep apnea
US-2025074899-A1 · Mar 6, 2025 · US
Combination of a task1/3 channel blocker with a muscarinic receptor antagonist for the treatment of sleep apnea
US-2025057846-A1 · Feb 20, 2025 · US
Combination of an a2-adrenoceptor subtype c (alpha-2c) antagonist with a norepinephrine reuptake inhibitor for the treatment of sleep apnea
US-2025057828-A1 · Feb 20, 2025 · US
Combination of a task1/3 channel blocker with a p2x3 receptor antagonist for the treatment of sleep apnea
US-2025057845-A1 · Feb 20, 2025 · US
Combination of a task1/3 channel blocker with a norepinephrine reuptake inhibitor for the treatment of sleep apnea
US-2025049803-A1 · Feb 13, 2025 · US
2,3-dihydrobenzo [b][1, 4]dioxin-2-ylmethyl)piperazin-1-yl derivates for the treatment of sleep apnea
US-2025049788-A1 · Feb 13, 2025 · US
Diazabicyclic substituted imidazopyrimidines and their use for the treatment of breathing disorders
US-12180227-B2 · Dec 31, 2024 · US
Combination of an alpha2-adrenoceptor subtype c (alpha-2c) antagonist with a task1/3 channel blocker for the treatment of sleep apnea
US-2024000767-A1 · Jan 4, 2024 · US
Recent patents
Latest publications not already listed above.
Inhibitors of adrenoreceptor adrac2
US-2023115270-A1 · Apr 13, 2023 · US
Substituted diazahetero-bicyclic compounds and their use
US-2022259228-A1 · Aug 18, 2022 · US
Combination of an alpha2-adrenoceptor subtype c (alpha-2c) antagonists with a task1/3 channel blocker for the treatment of sleep apnea
US-2022218695-A1 · Jul 14, 2022 · US
Arylquinoziline derivatives as alpha2-adrenoceptor subtype c (alpha-2c) antagonists for the treatment of sleep apnea
US-2022218677-A1 · Jul 14, 2022 · US
Combination of an ?2-adrenoceptor subtype c (alpha-2c) antagonists with a task1/3 channel blocker for the treatment of sleep apnea
US-2022218700-A1 · Jul 14, 2022 · US
Diazabicyclic substituted imidazopyrimidines and their use for the treatment of breathing disorders
US-2022017540-A1 · Jan 20, 2022 · US
?2-adrenoceptor subtype c (alpha-2c) antagonists for the treatment of sleep apnea
US-2022016113-A1 · Jan 20, 2022 · US
Substituted bridged diazepane derivatives and use thereof as TASK-1 and TASK-3 inhibitors
US-11208422-B2 · Dec 28, 2021 · US
Alpha-2-adrenoceptor subtype c (alpha-2c) antagonists for the treatment of sleep apnea
US-2021338662-A1 · Nov 4, 2021 · US
Diazabicyclic substituted imidazopyrimidines and their use for the treatment of breathing disorders
US-11098063-B2 · Aug 24, 2021 · US
Substituted diazahetero-bicyclic compounds and their use
US-2021024545-A1 · Jan 28, 2021 · US
2-phenyl-3-(piperazinomethyl)imidazo[1,2-A]pyridine derivatives as blockers of task-1 and task-2 channels, for the treatment of sleep-related breathing disorders
US-10759794-B2 · Sep 1, 2020 · US
Substituted bridged diazepane derivatives and use thereof as task-1 and task-3 inhibitors
US-2020140461-A1 · May 7, 2020 · US
Diazabicyclic substituted imidazopyrimidines and their use for the treatment of breathing disorders
US-2020109155-A1 · Apr 9, 2020 · US
Pharmaceutical dosage forms containing task-1 and task-3 channel inhibitors, and the use of same in breathing disorder therapy
US-2020093737-A1 · Mar 26, 2020 · US
Pharmaceutical dosage forms containing task-i and task-3 channel inhibitors, and the use of same in breathing disorder therapy
US-2020085734-A1 · Mar 19, 2020 · US
N3-cyclically substituted thienouracils and use thereof
US-2020016159-A1 · Jan 16, 2020 · US
Substituted N,2-diarylquinoline-4-carboxamides and the use thereof as anti-inflammatory agents
US-10479765-B2 · Nov 19, 2019 · US
Heterocyclylmethyl-thienouracile as antagonists of the adenosine-A2B-receptor
US-10428083-B2 · Oct 1, 2019 · US
Substituted perhydropyrrolo[3,4-c]pyrrole derivatives and the use of same
US-10414765-B2 · Sep 17, 2019 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Bayer Pharma AG | 30 |
| Bayer Ag | 23 |
| Bayer Ip Gmbh | 9 |
| Delbeck Martina | 5 |
| Kolkhof Peter | 4 |
Top CPC classifications
Most common classification codes across this inventor's patents.